farmakeftiki-eteria-diloni-pos-eksaplonete-o-karkinos-meso-embolion-1

epa01660055 A view of a sign for Merck & Co. at the company’s complex in Rahway, New Jersey, USA, on 09 March 2009. Merck & Co. is announced that it is buying Schering-Plough Corp. for $41.1 billion in stock and cash, a deal spawned by the difficult economic climate being faced by the drug industry. EPA/JUSTIN LANE